SLC2A9-AS1

Across TCGA pan-cancer cohorts, SLC2A9-AS1 RNA differs between tumor and matched normal tissue in 10 of 18 cancer types tested, making tumor–normal expression one of SLC2A9-AS1’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where SLC2A9-AS1 RNA is repressed in tumor relative to normal tissue. In most cancer types SLC2A9-AS1 is over-expressed in tumor, although a few such as COAD and KICH show the opposite, repressed pattern.

COAD, KICH, and THCA are the cancer types where SLC2A9-AS1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in SLC2A9-AS1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	Female	II,III,IV	−0.908	<.001	11	view →
KICH	All	II,III,IV	−1.760	<.001	10	view →
THCA	Male	III,IV	−1.252	<.001	10	view →
KIRP	Male	All	−0.698	<.001	9	view →
BRCA	All	II,III,IV	+0.327	.001	6	view →
READ	Female	All	−1.598	<.001	5	view →
BLCA	All	All	+0.685	.016	5	view →
PRAD	All	All	−0.871	<.001	2	view →
KIRC	All	II,III,IV	−0.253	.022	2	view →
LUAD	Female	II,III,IV	−0.394	.018	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 10 strongest of 10 lineages.

SLC2A9-AS1–COAD

Open the COAD breakdown →